Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
3,441
Views
1
CrossRef citations to date
0
Altmetric
COVID-19
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
Manuela Di Fuscoa Pfizer Inc, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0003-0079-7331
, https://orcid.org/0000-0003-0079-7331
Kinga Marczellb Evidera, Budapest, Hungary
, Elizabeth Thoburnc Pfizer, Inc, Collegeville, PA, USA
, Timothy L. Wiemkenc Pfizer, Inc, Collegeville, PA, USA
, Jingyan Yanga Pfizer Inc, New York, NY, USA;d Institute for Social and Economic Research and Policy, Columbia University, New York, NY, USAhttps://orcid.org/0000-0001-5523-649X
& Benjamin Yarnoffe Evidera, Bethesda, USA
Pages 509-524
|
Received 08 Feb 2023, Accepted 16 Mar 2023, Published online: 04 Apr 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.